About LifeSpan BioSciences, Inc. (LSBio)

Founded in 1995 by Drs. Joseph Brown and Glenna Burmer, LSBio was established as a molecular pathology company with a focus on protein localization in diseased human tissues by IHC. Through the experience gained by executing thousands of IHC studies, and generating and testing many thousands of antibodies, LSBio has become a world leader in the antibody industry, with a reputation for excellence. 

 

LSBio has a catalog of 550,000 monoclonal and polyclonal antibodies to 20,000 targets. Antibodies are available for most species and all major research applications, such as immunoblotting, IHC, immunofluorescence, and fluorescence-activated cell sorting. Through extensive ongoing in-house testing, more than 14,000 of these antibodies have also been identified as exceptional IHC reagents, and given the IHC-plus™ brand.  

 

LSBio also offers 30,000 high-quality immunoassays, including Sandwich ELISA (enzyme-linked immunosorbent assay) kits, Competitive EIA (Enzyme Immunoassay) kits, as well as cell-based and DNA-binding kits.   

 

LSBio also offers 45,000 native protein extracts as well as engineered recombinant proteins in the form of cell lysates or highly-purified reagents. 

 

More recently LSBio has released their growing collections of Assay Kits and BioChemicals intended to complement their other product lines for the research community. 

 

For more than a decade researchers have been relying upon LSBio’s expertise to fulfill their molecular pathology outsourcing needs. 

 

LSBio stands behind the quality of its products and services and offers unparalleled customer service and support. In the years to come, LSBio plans to continue expanding its catalog of high-quality proteomics products, providing its customers with excellent reagents, services, and support to accelerate their research.